Lv11
70 积分 2026-02-02 加入
Copper depletion boosts CNS leukemia therapy by inhibiting nucleotide synthesis through impairment of mitochondrial complex IV activity
4小时前
已完结
Green tea polyphenol EGCG reverse cisplatin resistance of A549/DDP cell line through candidate genes demethylation
29天前
已完结
Combination of Olaparib, Durvalumab, and Fulvestrant in Patients with Advanced ER+/HER2− Breast Cancer and Selected Genomic Alterations: Results of the DOLAF Trial
1个月前
已完结
PARP inhibitor-based combination therapies: enriching synergistic forces against BRCA-mutated metastatic breast cancer
1个月前
已完结
Data from Safety, Immunologic, and Clinical Activity of Durvalumab in Combination with Olaparib or Cediranib in Advanced Leiomyosarcoma: Results of the DAPPER Clinical Trial
1个月前
已完结
Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial)
1个月前
已完结
Anti-EGFR therapy can overcome acquired resistance to the third-generation ALK-tyrosine kinase inhibitor lorlatinib mediated by activation of EGFR
1个月前
已完结
ALK inhibitors in the treatment of advanced NSCLC
1个月前
已完结
The therapeutic inhibition of topoisomerase inhibitor and crizotinib combination in EGFR wild and mutant lung cancer cells
1个月前
已完结
Synergistic effects of crizotinib and radiotherapy in experimental EML4–ALK fusion positive lung cancer
1个月前
已完结
皖公网安备34019202002308
